JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma-Reference-Cited by-同舟云学术

JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma

Published:2016-09-06 Issue:1 Volume:2 Page:
ISSN:2056-5968
Container-title:Cell Discovery
language:en
Short-container-title:Cell Discov

Author:

Titz Bjoern,Lomova Anastasia^ORCID,Le Allison,Hugo Willy^ORCID,Kong Xiangju,ten Hoeve Johanna,Friedman Michael,Shi Hubing,Moriceau Gatien,Song Chunying,Hong Aayoung,Atefi Mohammad,Li Richard,Komisopoulou Evangelia,Ribas Antoni,Lo Roger S,Graeber Thomas G^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry

Link

http://www.nature.com/articles/celldisc201628.pdf

Reference95 articles.

1. Korn EL, Liu P-Y, Lee SJ et al. Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol 2008; 26: 527–534.

2. Davies H, Bignell GR, Cox C et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949–954.

3. Greaves WO, Verma S, Patel KP et al. Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma. J Mol Diagn 2013; 15: 220–226.

4. Chapman PB, Hauschild A, Robert C et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507–2516.

5. Tsai J, Lee JT, Wang W et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci USA 2008; 105: 3041–3046.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The lincRNA JUNI regulates the stress-dependent induction of c-Jun, cellular migration and survival through the modulation of the DUSP14-JNK axis;Oncogene;2024-04-02

2. Cancer Cell Biomechanical Properties Accompany Tspan8-Dependent Cutaneous Melanoma Invasion;Cancers;2024-02-06

3. The stress-induced lincRNAJUNIis a critical factor for cancer cell survival whose interactome is a prognostic signature in clear cell renal cell carcinoma;2023-10-26

4. Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response;Cell Reports;2023-07

5. BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge;Cancers;2023-05-04